Copyright
©The Author(s) 2016.
World J Gastroenterol. Mar 28, 2016; 22(12): 3341-3354
Published online Mar 28, 2016. doi: 10.3748/wjg.v22.i12.3341
Published online Mar 28, 2016. doi: 10.3748/wjg.v22.i12.3341
Figure 3 Levels of AQP9 in hepatocellular carcinoma of different differentiation.
A: Analysis of AQP9 protein expression by immunohistochemistry. a: AQP9 expression was high in normal liver samples; b: AQP9 expression was weak in well-differentiated HCC samples; c: AQP9 expression was high in normal liver samples; d: AQP9 expression was moderate in moderately differentiated HCC samples; e: AQP9 expression was high in normal liver samples; f: AQP9 expression was low in poorly differentiated HCC samples (magnification × 200, bar = 50 μm). B: The protein levels of AQP9 in HCC of different differentiation corresponded to their immunohistochemistry results: Tumor 1, well-differentiated HCC sample; tumor 2, moderately differentiated HCC sample; and tumor 3, poorly differentiated HCC sample. HCC: Hepatocellular carcinoma.
- Citation: Peng R, Zhao GX, Li J, Zhang Y, Shen XZ, Wang JY, Sun JY. Auphen and dibutyryl cAMP suppress growth of hepatocellular carcinoma by regulating expression of aquaporins 3 and 9 in vivo. World J Gastroenterol 2016; 22(12): 3341-3354
- URL: https://www.wjgnet.com/1007-9327/full/v22/i12/3341.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i12.3341